Background: Over the last two to three decades there has been a marked decrease in certain bacterial infections in Turkey. One of them is tuberculosis. Of note, statistics published by the Turkish Ministry of Health (MoH) show decreasing pulmonary tuberculosis (PTB), but on the other hand, increasing extrapulmonary tuberculosis (EPTB). The most common form of EPTB is tuberculous cervical lymphadenitis (TCL). The increase in the number of TCL cases despite the decline in cases of PTB is seen as a paradoxical issue. In contrast there has been an increase in the number of oropharyngeal tularemia cases in the last decade in Turkey. The aim of this study was to draw attention to the importance of differentiating between TCL and tularemia lymphadenitis, because these diseases may have a similar histopathological appearance. Methods: Thirty-two cases diagnosed as TCL were identified from the archives of a pathology laboratory (Patomer Pathology Laboratory, Bursa, Turkey). PCR tests for Francisella tularensis and Mycobacterium tuberculosis were carried out on the paraffin tissue blocks of these cases. At the same time, statistical data on PTB and EPTB for the period 1996-2010 were retrieved from the MoH and reviewed. Statistics related to tularemia, which has been diagnosed since 1988 and has been increasing in the last 10 years, were obtained from the Department of Zoonoses of the MoH. Results: Six out of 32 (19%) cases who had previously been diagnosed with 'casseifying granulomatous lymphadenitis consistent with tuberculosis' were found to be positive for tularemia by PCR test of the cervical lymph nodes. Conclusions: Oropharyngeal tularemia should be kept in mind in the differential diagnosis of cervical lymphadenitis in widespread geographic regions of the Northern Hemisphere, including the Asian continent. In particular, if granulomatous inflammation with necrosis is seen histopathologically, tularemia should be excluded before making the diagnosis of TCL.
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unchlorinated water); this is seen especially in rural areas of countries like Turkey. [1] [2] [3] [4] In oropharyngeal tularemia, the long duration of involvement of the lymph nodes, which appear as large masses, may lead to concern for a malignancy, such as lymphoma. This disease may also be confused with chronic infectious diseases such as tuberculosis (TB). Therefore, invasive interventions, like biopsy, and other numerous medical tests are performed. Malignancy can be excluded by histopathological examination. However, if the lymph nodes reveal necrotizing granulomatous inflammation, the patient may undergo unnecessary long-term anti-TB treatment because this histological finding is usually considered sufficient proof for TB in an endemic area, which is a misconception. This approach is common, especially in countries where routine childhood bacille Calmette-Gué rin (BCG) immunization programs causing purified protein derivative (PPD) positivity are continued. 4 For the last two to three decades there has been a marked decrease in certain specific bacterial infections in Turkey. The most important of these is TB. Interestingly, statistical analyses show decreasing pulmonary tuberculosis (PTB) but increasing extrapulmonary tuberculosis (EPTB). The most common form of EPTB is tuberculous cervical lymphadenitis (TCL). The increase in the number of TCL cases despite the decline in cases of PTB is seen as a paradoxical issue. In contrast, there has been an increase in the number of oropharyngeal tularemia cases reported over the last decade in Turkey. 4 In this study, we performed a retrospective reevaluation of cases previously diagnosed as TCL just by histological examination showing granulomatous inflammation and PPD positivity, without microbiological confirmation.
Materials and methods

Samples
Samples were retrieved from the archives of a pathology laboratory (Patomer Pathology Laboratory, Bursa, Turkey). Paraffin-embedded cervical lymph nodes that had been removed in ENT clinics from 32 patients during the years 2006-2011 were included in this study. Only lymph node material showing granulomatous lymphadenitis and reported as being consistent with TCL was included. There were no exclusion criteria other than an insufficient tissue sample for molecular study. These samples had been fixed in 3.7% formaldehyde solution and had been processed and paraffin-embedded in the pathology laboratory. Paraffin blocks were cut into 3-5-mm sections and stained with hematoxylin and eosin.
DNA isolation
All samples were studied for Francisella tularensis DNA by PCR in the Laboratory of Medical Microbiology of Kocaeli University. DNA was extracted from two or three 25-mm sections of the paraffin-embedded lymph node specimens. 5 The Qiagen DNeasy Blood and Tissue Kit was used for DNA isolation following the deparaffinization procedure. Amplification of the b-actin housekeeping gene was performed on all samples to ensure the presence of intact DNA.
Real-time TaqMan PCR
DNA amplification of F. tularensis was performed by real-time TaqMan PCR using previously published primer and probe sets targeting the ISFtu2 gene. 5, 6 The primer and probe sets targeting the ISFtu2 genome were as follows: sense primer 5 0 -ACAAGAAGT-CATGCTTGATTCAAC-3 0 , anti-sense primer 5 0 -GGATTACCTAAAG-CATCAGTCATAGC-3 0 , probe sequence ATAGCAAGAGCACAT (Dye 6-FAM).
Reactions were run in 25-ml volumes containing 2 ml of sample DNA. The final MgCl 2 concentration was 5 mM, whereas the primers and probes were 500 nM and 100 nM, respectively. The annealing temperature for the TaqMan assay was 60 8C. TaqMan PCR conditions were as follows: activation was one cycle of 95 8C for 3 min, and amplification and detection was 40 cycles of 94 8C for 10 s and 65 8C for 30 s.
Positive and negative DNA controls were used in all PCR experiments. Two types of control were used on each PCR plate in all PCR experiments. F. tularensis subsp. holarctica NCTC 10857 was used as positive control. Reagent blanks and Brucella DNA were used as negative controls.
All samples were also screened for Mycobacterium tuberculosis. Primers rpo95 (5 0 -CCACCCAGGACGTGGAGGCGATCACACCG-3 0 ) and rpo397 (5 0 -GTCAACCCGTTCGGGTTCATCGAAACG-3 0 ) were used to amplify a 329-bp product, which includes the relevant segment of rpoB. 7 Statistical data on PTB and EPTB for the period 1996-2010 were retrieved from the Turkish Ministry of Health (MoH) and reviewed. 8 Statistics related to tularemia, which has been diagnosed since 1988 and has been increasing in the last 10 years, were obtained from the Department of Zoonoses of the MoH.
Results
The patients were aged between 17 and 77 years (mean 49 years); 11 were male (34.3%) and 21 were female (65.7%). Histopathological examination of the slides revealed lymph nodes with necrosis and granulomatous inflammation ( Figure 1 ). Although acid-fast staining was negative for acid-alcohol-resistant bacilli (AARB) in all cases, the histopathological diagnosis was considered and reported to be casseifying granulomatous inflammation consistent with TB. The presence of F. tularensis DNA in the cervical lymph node tissue samples was shown by real-time TaqMan PCR in six of the 32 cases (19%). All six F. tularensis PCRpositive lymph nodes were negative for M. tuberculosis PCR and were also negative for AARB (Table 1) .
Statistical data from the Department of Zoonoses, MoH regarding cases of TB and tularemia in Turkey indicated decreasing numbers of PTB and increasing numbers of EPTB and tularemia ( Table 2 ). 
Discussion
Suppurative inflammation and abscess formation is one of the most common complications of tularemia. If treatment is started in the first 3 weeks of the disease, this complication may be avoided. However, since oropharyngeal tularemia cases are often considered to be streptococcal tonsillitis at first presentation, the disease is often treated with penicillins or other beta-lactam antibiotics (ampicillin-sulbactam, amoxicillin-clavulanic acid, cephalosporins, etc.). The second mistake made in these patients is changing the treatment to another antibiotic or extending the treatment duration due to unresponsiveness. As a result, it takes a few weeks to months to make a diagnosis of tularemia in most patients. With unresponsiveness to these treatment modalities, multiple lymphadenopathies may occur in the head and neck region. Because of the fear and suspicion of malignancy, probable tularemia patients are directed to ENT or other surgery clinics. Since tularemia is not kept in mind, the patient may undergo surgical lymph node excision. Moreover, due to the granulomatous inflammation on histopathological examination, the diagnosis of TCL is often made, which is another misdiagnosis for the tularemia patient. 4, 9, 11, 12 The total number of TB cases seems to be decreasing definitively in Turkey. 8 Despite all these improvements, a significant increase in the numbers of TCL and EPTB cases was observed between the years 2005 and 2010, which cannot be explained easily. After careful evaluation, a steady growth in the number of diagnoses of EPTB versus PTB was observed during the same period.
With regard to the range of patient ages, the age-group 15-34 years appears to be predominant. With this in mind, the correctness of the diagnosis of TCL should be evaluated. It seems that granulomatous lymphadenitis is one of the main histopathological features in oropharyngeal tularemia, as in TB. The fact that necrosis, frequently mimicking casseification necrosis, may also be seen in tularemia, makes it particularly crucial to differentiate TCL from tularemia lymphadenitis. [9] [10] [11] [12] According to many clinicians, for the diagnosis of TCL in daily practice in TB endemic and low income countries, it is usually sufficient to see casseification necrosis in excisional biopsies of the lymph nodes and to report the histopathological diagnosis as 'casseifying granulomatous lymphadenitis'. Bacteriological investigations (smear, culture) of these samples usually give negative results due to the small number of bacteria. The PCR study for M. tuberculosis in tissue samples also gives negative results in half of the cases. 13 Therefore this test is available in a limited number of medical centers. It is also important to keep in mind that PPD positivity is very common in countries like Turkey where the BCG vaccine is routinely applied. So, PPD positivity does not always mean neither latent nor active TB infection in such countries.
Mycobacterial disease may present with the same kind of local lymphadenopathy as tularemia, although at a much slower rate of development. It is evident that the diagnosis of 'casseifying granulomatous lymphadenitis' is not sufficient to differentiate between TCL and tularemia, since the same histopathological features may be present in both of these diseases. The presence of casseifying necrosis, no neutrophils, and, occasionally, intracellular and/or extracellular AARB in granulomas are the findings in TCL. On the other hand, the borders of granulomas in tularemia are not sharp and fewer giant cells are seen inside them. 9 The histopathological features of TCL are closely related to the duration of the disease. In the hyper-acute period, reactive follicular hyperplasia, non-necrotizing granulomas, and diffuse histiocytes may be seen. Abscess formation occurs in the second week and necrosis becomes prominent in the fourth week. On the other hand, necrosis may be seen in the very early period, such as on the fifth day after the onset of symptoms. Suppurative inflammation of the lymph nodes involved may also occur after specific antibiotherapy is started. The granulomatous inflammation surrounding the necrosis consists of foamy and/or epithelioid histiocytes and occasional giant cells. In most cases, the inflammatory process may expand out of the lymph nodes. Silver staining procedures (Steiner, Dieterle, and Warthin-Starry) may show the microorganisms located inside the macrophages. The direct fluorescein antibody test and PCR tests may be done with aspiration material. Since PCR may also give positive results after antibiotherapy, it is a useful test.
In the differential diagnosis of necrotizing lymphadenitis the following must be considered: staphylococcal and streptococcal infections, cytomegalovirus, Epstein-Barr virus, mycobacteriosis, toxoplasmosis, lymphoma, brucellosis, and tularemia, even though the prevalence rates of this disease are lower. 11 In regions with epidemic tularemia, we strongly believe that patients diagnosed with TCL by histopathology alone and who are not responding to treatment or who are experiencing an atypical course, should be investigated for tularemia. In patients with unilateral or bilateral lymphadenopathy and a history of acute tonsillopharyngitis that is unresponsiveness to beta-lactams, tularemia should be considered in the differential diagnosis, even in regions where tularemia has not previously been reported.
The frequency of certain specific infectious diseases including TB is decreasing in Turkey. However, while the total number of TB cases is decreasing, the proportion of EPTB cases (mostly TCL) is noticeably increasing. Meanwhile, the number of tularemia cases has also increased over the last two decades (1988-2011) due to unexplained reasons, and this is a paradoxical issue. 8, 10, 11, [14] [15] [16] [17] In a very recent study, Karabay et al. investigated the presence of anti-tularemia antibodies by tularemia microagglutination test in patients diagnosed with TCL in a country-wide setting in Turkey. 17 The study showed 10-20-times more anti-tularemia antibody-positive cases in the TCL group than in the control group. The fact that the study was carried out over a wide area endemic for both tularemia and TB with a high number of cases (1170 TCL cases) and controls (596 healthy volunteers) makes the results of the study more significant. Our study was mainly based on the molecular detection of F. tularensis in cervical lymph node tissue samples previously diagnosed as TCL and makes another strong contribution to resolving the issue of overdiagnosis of TCL due to histopathological examination results, instead of the diagnosis of oropharyngeal tularemia, in areas endemic for both TB and tularemia. To the best of our knowledge our study is the first original study to show the importance of F. tularensis DNA screening in human cases previously diagnosed as TCL only by histopathology. A number of studies conducted in Europe and Asia, including the first one in 1997 by Sjostedt et al., have shown the PCR amplification of F. tularensis DNA in different tissues. 18, 19 Lamps et al. found 14 of 15 (93%) human and non-human primate cases to be positive for F. tularensis DNA by PCR analysis. F. tularensis DNA was detected in all the types of tissue tested, including lymph, liver, spleen, kidney, heart, lung, meninges, and gut. 5 Versage et al. tested the ability of the ISFtu2, tul4, and 23kDa TaqMan assays to identify F. tularensis in biological specimens from infected mouse tissues. Whereas the DNA isolated from the spleens and livers of control mice were negative in the assays, DNA isolated from the tissues of F. tularensis-infected mice were consistently positive by all three assays. In addition, tissue samples spiked with known concentrations of F. tularensis DNA showed no evidence of inhibition. They also reported that the combined ISFtu2, 23kDa, and tul4 TaqMan assay accurately detected F. tularensis in 46 of the 46 carcasses (100%). None of the 40 (0%) F. tularensis-negative tissues were positive by the TaqMan assays. Despite the challenges associated with culturing F. tularensis from carcasses, the multitarget TaqMan assay detected F. tularensis in 100% of cases, demonstrating that the multi-target TaqMan assay is useful for the detection of F. tularensis in complex specimens. 20 In most European countries including Germany, those of the Balkan Peninsula, and many East European countries, the increase in tularemia cases is also drawing attention. [21] [22] [23] Tularemia is thought to be one of the diseases whose epidemiological features are changing owing to varying climate conditions, or, in more popular terms, global warming. This means that the classical definitions that are used to describe tularemia, such as ''a zoonotic disease seen in the Northern Hemisphere between the 30 th and 71 st latitudes'' is changing. In other words, with its recent increasing potential, tularemia may be a threat to a larger population living over a widespread geographical area in the near future. Tularemia may become an infectious disease affecting people living not only in North America, Europe, and the Balkan Peninsula, but also Russia, the Turkic Republics of Central Asia, China, India, and Japan. This shows how important tularemia is in the differential diagnosis in such a wide geographical area, where PTB and EPTB are common. It has been reported that patients with tularemia may be being misdiagnosed and treated for TCL in centers not only in Turkey, 12 but also in other countries endemic for both TB and tularemia. This situation may inevitably lead to unnecessary long-term (!6 months) anti-TB treatment, 12 with its many side effects. However, the clinical suspicion of tularemia may lead to an early diagnosis of the disease and treatment with appropriate antibiotics; 10-21 days of streptomycin, gentamicin, ciprofloxacin, doxycycline, or chloramphenicol may be efficient and sufficient.
A limitation of this study is that it was mainly based on cervical lymph node tissue specimens archived as consistent with TCL after histopathological examination in a private pathology laboratory. Our study did not include clinical or epidemiological data. We have no information at this time on TB culture of fresh lymph node samples. We did not have information on the patients' response to anti-TB drugs. The results have to be considered from the histopathological and microbiological point of view.
In conclusion, to avoid misdiagnosis and unnecessary TB treatment, we suggest that patients with cervical lymphadenitis and a neck mass and/or history of tonsillopharyngitis in the gradually expanding endemic area should be evaluated for tularemia. 4, 11, 24 If casseifying granulomatous lymphadenitis is present, then risk factors and contacts related to TB and tularemia, especially oropharyngeal tularemia and other glandular forms of tularemia (glandular, ulceroglandular, oculoglandular), should be determined by taking a detailed history, the patient should be investigated for a BCG scar, bacteriological isolation studies besides pathological examination should be carried out, if possible PCR tests for TB and tularemia should be done, agglutination tests for tularemia should be applied, and tuberculin testing and/or interferon-gamma release tests (Quantiferon and T-SPOT.TB) for TB should be done. We suggest that the differential diagnosis of granulomatous lymphadenitis cases is made by common consensus of experts from pathology, infectious diseases, otorhinolaryngology, pulmonary diseases, and also internal medicine.
